BackTC BioPharm (Holdings) plc - Warrants (08/02/2027) Overview
TC BioPharm (Holdings) plc - Warrants (08/02/2027)

TC BioPharm (Holdings) plc - Warrants (08/02/2027) Return on Equity

Valuation check: TCBPW's ROE is -794.56%, below the sector sector average of 11.64%.

Get informed when a big investor buys or sells

+ Follow

ROE

-794.56%

Return on Equity

-794.56%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

TC BioPharm (Holdings) plc - Warrants (08/02/2027) (TCBPW) FAQ

TC BioPharm (Holdings) plc - Warrants (08/02/2027) posts a ROE of -794.56%. That is below the sector sector average of 11.64%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

For its sector stocks, a ROE near 11.64% is typical. TC BioPharm (Holdings) plc - Warrants (08/02/2027)'s -794.56% is lower that level. That is roughly 6928.1% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

TC BioPharm (Holdings) plc - Warrants (08/02/2027)'s ROE moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is -794.56%; use YoY and peer views to separate noise from signal.

Context for TCBPW's ROE usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 11.64%), and (3) consistency with growth and profitability. This page covers the first two; TC BioPharm (Holdings) plc - Warrants (08/02/2027)'s other metric pages and overview cover the third.